DARE
Dare Bioscience Inc
NASDAQ: DARE · HEALTHCARE · BIOTECHNOLOGY
$2.28
+8.57% today
Updated 2026-04-30
Market cap
$30.72M
P/E ratio
—
P/S ratio
29.82x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Dare Bioscience Inc (DARE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-143.70%
ROE
-2,543.00%
ROA
-31.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $305000.00 | $-19.56M | -19.02% | -6,189.51% | -6,414.10% |
| 2012 | $625000.00 | $-22.10M | 100.00% | -3,452.00% | -3,536.16% |
| 2013 | $6000.00 | $-17.14M | 100.00% | -264,333.33% | -285,716.67% |
| 2014 | $80000.00 | $-23.34M | 100.00% | -25,348.75% | -29,177.50% |
| 2015 | $0.00 | $-39.59M | — | — | — |
| 2016 | $766000.00 | $-39.30M | 47.78% | -4,850.39% | -5,131.20% |
| 2017 | $0.00 | $-11.50M | — | — | — |
| 2018 | $0.00 | $-16.74M | — | — | — |
| 2019 | $0.00 | $-14.26M | — | — | — |
| 2020 | $0.00 | $-27.40M | — | — | — |
| 2021 | $10.00M | $-38.70M | -1.00% | -390.69% | -386.96% |
| 2022 | $10.00M | $406.80M | 100.00% | -313.85% | 4,068.02% |
| 2023 | $2.81M | $-30.16M | -670.62% | -1,101.89% | -1,074.17% |
| 2024 | $9784.00 | $-4.05M | -146,110.22% | -239,692.20% | -41,430.90% |
| 2025 | $1.03M | $-13.40M | -137.55% | -1,315.51% | -1,300.66% |